Malignant Hyperthermia response training

The predicted prevalence of Malignant Hyperthermia, is 1 in 2000 cases.

 Is your team prepared? 

Chemical agents used for anesthesia have been identified as triggering agents for MH. Heat and exercise intolerance may be a sign of MH susceptibility.  Succinylcholine, Halothane, Sevoflurane and Desflurane are anesthetic agents noted statistically significant as triggers of MH. The risk increases when these agents are combined. A study in New York State from 2001 to 2005 found MH prevalence in males 2.5 to 4.5 times more than females. 

BPM offers a target simulation course to prepare you and your team to respond with purpose and speed when faced with a malignant hyperthermia situation. In this course students will;

  • Understand and articulate the etiology of Malignant Hyperthermia
  • Learn and apply screening techniques to identify at risk patients
  • Locate, access and deploy facilities MH response kits and plans
  • Refresh and practice best practices in mixing and dosing Dantrolene
  • Discuss and perform a simulated MH case in the operating environment
  • Demonstrate knowledge retention through didactic and formal evaluation

This course is pending CNE accreditation.

Class Testimonials

“Ben and his team at Best Practice have been a life saver for us at RMSC. They have made getting our needed educated easy and they have been so accommodating to our busy schedule. Everyone has been so professional and pleasant to work with, I am happy to have them as part of our team.”

L. A., Rocky Mountain Surgical Center

Director of Clinical Services